Scott C. Mateer
PhD, Division of Biomedical Sciences, University of Texas Southwestern Medical Center
Office: SC 1020 (Armstrong)
Phone: (912) 344-3101
Personal Web Page
Principles of Biology I, Principles of Biology I (Honors), Cell Biology, Cancer Biology, Cell and Molecular Biology Laboratory, Molecular Biology, Molecular Development, Research, Internship
Biocatalysis is the use of microbes or their enzymes to generate chiral specific organic compounds that can be used as the building blocks for pharmaceuticals such as Prozac™. In short, biocatalysis is the use of little bugs to make big drugs. The ability of enzymes to generate these stereospecific molecules is not clearly understood. Dr. Scott Mateer, in collaboration with Dr. Brent Feske and Dr. Cliff Padgett, are trying to understand the molecular mechanisms that regulate an enzyme’s stereoselectivity via mutagenesis of specific yeast reductases and subsequent analysis of the mutant reductase’s ability to make chiral molecules. Their work is currently being funded by an NSF-RUI grant.
Last updated: 8/1/2018